Cargando…
Uterine involvement in epithelial ovarian cancer and its risk factors
BACKGROUND: Epithelial ovarian cancer (EOC) is an extremely aggressive and lethal carcinoma. Specific data that identify high-risk groups with uterine involvement are not available. Thus, this study aimed to evaluate a gross number of women with EOC to obtain the frequency of uterine involvement and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653532/ https://www.ncbi.nlm.nih.gov/pubmed/34876191 http://dx.doi.org/10.1186/s13048-021-00925-7 |
_version_ | 1784611684979048448 |
---|---|
author | Zamani, Narges Mousavi, Azam Sadat Akhavan, Setare Sheikhhasani, Shahrzad Nikfar, Somayeh Feizabad, Elham Rezayof, Elahe Modares Gilani, Mitra |
author_facet | Zamani, Narges Mousavi, Azam Sadat Akhavan, Setare Sheikhhasani, Shahrzad Nikfar, Somayeh Feizabad, Elham Rezayof, Elahe Modares Gilani, Mitra |
author_sort | Zamani, Narges |
collection | PubMed |
description | BACKGROUND: Epithelial ovarian cancer (EOC) is an extremely aggressive and lethal carcinoma. Specific data that identify high-risk groups with uterine involvement are not available. Thus, this study aimed to evaluate a gross number of women with EOC to obtain the frequency of uterine involvement and its risk factors. METHODS: This retrospective observational study was conducted on 1900 histologically confirmed EOC women, diagnosed and treated in our tertiary hospital from March 2009 to September 2020. Data including their demographic, medical and pathological findings were collected. RESULTS: From 1900 histologically confirmed EOC women, 347 patients were eligible for participations. The mean age of study patients was 51.31 ± 11.37 years with the age range of 25 to 87 years. Uterine involvement was detected in 49.6% (173) of the patients either macroscopic (47.4%) or microscopic (52.6%) types. Uterine involvement was significantly associated with having AUB (P-value = 0.002), histological type of ovary tumor (P-value < 0.001), ovarian cancer stage (P-value < 0.001), and abnormal CA-125 concentration (P-value = 0.004). Compared to the other study patient, the patients with metastatic uterine involvement had significantly higher stage (p-value< 0.001), higher grade of ovary tumor (p-value = 0.008), serous histological type (p-value< 0.001), and a higher level of CA-125 concentration (p-value< 0.001). on the other hand, the patients with synchronous uterine cancer were significantly younger (p-value = 0.013), nulliparous (p-value< 0.001), suffered from AUB symptoms (p-value< 0.001) and had endometroid histological type (p-value = 0.010) of ovary cancer in comparison to other study patients. CONCLUSION: Considering the high prevalence of uterine involvement in EOC patients, ultrasound evaluation and/or endometrium biopsy assessment should be done before planning any treatment. |
format | Online Article Text |
id | pubmed-8653532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86535322021-12-08 Uterine involvement in epithelial ovarian cancer and its risk factors Zamani, Narges Mousavi, Azam Sadat Akhavan, Setare Sheikhhasani, Shahrzad Nikfar, Somayeh Feizabad, Elham Rezayof, Elahe Modares Gilani, Mitra J Ovarian Res Research BACKGROUND: Epithelial ovarian cancer (EOC) is an extremely aggressive and lethal carcinoma. Specific data that identify high-risk groups with uterine involvement are not available. Thus, this study aimed to evaluate a gross number of women with EOC to obtain the frequency of uterine involvement and its risk factors. METHODS: This retrospective observational study was conducted on 1900 histologically confirmed EOC women, diagnosed and treated in our tertiary hospital from March 2009 to September 2020. Data including their demographic, medical and pathological findings were collected. RESULTS: From 1900 histologically confirmed EOC women, 347 patients were eligible for participations. The mean age of study patients was 51.31 ± 11.37 years with the age range of 25 to 87 years. Uterine involvement was detected in 49.6% (173) of the patients either macroscopic (47.4%) or microscopic (52.6%) types. Uterine involvement was significantly associated with having AUB (P-value = 0.002), histological type of ovary tumor (P-value < 0.001), ovarian cancer stage (P-value < 0.001), and abnormal CA-125 concentration (P-value = 0.004). Compared to the other study patient, the patients with metastatic uterine involvement had significantly higher stage (p-value< 0.001), higher grade of ovary tumor (p-value = 0.008), serous histological type (p-value< 0.001), and a higher level of CA-125 concentration (p-value< 0.001). on the other hand, the patients with synchronous uterine cancer were significantly younger (p-value = 0.013), nulliparous (p-value< 0.001), suffered from AUB symptoms (p-value< 0.001) and had endometroid histological type (p-value = 0.010) of ovary cancer in comparison to other study patients. CONCLUSION: Considering the high prevalence of uterine involvement in EOC patients, ultrasound evaluation and/or endometrium biopsy assessment should be done before planning any treatment. BioMed Central 2021-12-07 /pmc/articles/PMC8653532/ /pubmed/34876191 http://dx.doi.org/10.1186/s13048-021-00925-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zamani, Narges Mousavi, Azam Sadat Akhavan, Setare Sheikhhasani, Shahrzad Nikfar, Somayeh Feizabad, Elham Rezayof, Elahe Modares Gilani, Mitra Uterine involvement in epithelial ovarian cancer and its risk factors |
title | Uterine involvement in epithelial ovarian cancer and its risk factors |
title_full | Uterine involvement in epithelial ovarian cancer and its risk factors |
title_fullStr | Uterine involvement in epithelial ovarian cancer and its risk factors |
title_full_unstemmed | Uterine involvement in epithelial ovarian cancer and its risk factors |
title_short | Uterine involvement in epithelial ovarian cancer and its risk factors |
title_sort | uterine involvement in epithelial ovarian cancer and its risk factors |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653532/ https://www.ncbi.nlm.nih.gov/pubmed/34876191 http://dx.doi.org/10.1186/s13048-021-00925-7 |
work_keys_str_mv | AT zamaninarges uterineinvolvementinepithelialovariancanceranditsriskfactors AT mousaviazamsadat uterineinvolvementinepithelialovariancanceranditsriskfactors AT akhavansetare uterineinvolvementinepithelialovariancanceranditsriskfactors AT sheikhhasanishahrzad uterineinvolvementinepithelialovariancanceranditsriskfactors AT nikfarsomayeh uterineinvolvementinepithelialovariancanceranditsriskfactors AT feizabadelham uterineinvolvementinepithelialovariancanceranditsriskfactors AT rezayofelahe uterineinvolvementinepithelialovariancanceranditsriskfactors AT modaresgilanimitra uterineinvolvementinepithelialovariancanceranditsriskfactors |